Anacor Pharmaceuticals, Inc.
| Nasdaq: ANAC
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company has discovered seven compounds that are currently in development including its lead compounds: tavaborole, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory of atopic PDE-4 inhibitor for the treatment dermatitis and psoriasis; GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria. The company was founded by Stephen J. Benkovic and Lucy Shapiro on December 14, 2000 and is headquartered in Palo Alto, CA.